Published by Josh White on 7th August 2024
(Sharecast News) - Cell engineering company MaxCyte reported a robust financial performance for its second quarter on Wednesday, with total revenue reaching $10.4m, a 15% increase compared to the same period in 2023.
URL: http://www.digitallook.com/dl/news/story/34477745/...